Sofosbuvir Completed Phase 4 Trials for Hepatitis C Viral Infection / Beta-Thalassemia Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03961828Hyalornic Acid Level in β-Thalassemic Children Treated for Hepatitis C Virus